Sep 2012 BMC urology

Urinary levels of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein as a diagnostic biomarker in patients with bladder cancer.

Auteurs

Nitta Y, Konishi H, Makino T, Tanaka T, Kawashima H, Iovanna JL, Nakatani T, Kiyama H

Résumé

To assess the possibility of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein (HIP/PAP) as a biological marker for detecting Bladder cancer (BCa), we examined the expression of HIP/PAP in both BCa specimens and BCa cell lines and measured HIP/PAP levels in urine from patients with BCa.

Lire l‘article